Sometimes it’s tough to find high-quality companies trading at great prices. However, with the FTSE 100 having fallen by 6% in the last month alone, the task of doing so has been made just a little easier.
Certainly, the outlook for the wider market looks uncertain, with the Eurozone economy and Ebola fears weighing heavy on investors’ minds. However, for long term investors this presents an opportunity to buy great companies at reasonable prices.
Should you invest £1,000 in Abrdn right now?
When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Abrdn made the list?
With this in mind, here are five insurance stocks that seem to fit the bill and which could beat the FTSE 100 moving forward.
Aviva
Aviva’s (LSE: AV) turnaround plan is working. Indeed, the company’s bottom line is in much healthier shape than it was even two years ago, with earnings set to increase by 8% next year. Certainly, there is more work for management to do, but Aviva seems to be on the right path and looks set to increase dividends per share by an impressive 15.6% next year.
This would put shares in the company on a yield of 3.9% and, with a price to earnings (P/E) ratio of just 10.4, Aviva could prove to be a top performer over the medium to long term.
Prudential
When it comes to bottom line growth, Prudential (LSE: PRU) is super-reliable. Indeed, it has increased earnings in each of the last five years and is forecast to continue this trend over the next two years as well.
With a price to earnings growth (PEG) ratio of just 1 and a payout ratio of only 38%, Prudential seems to offer growth at a reasonable price, as well as strong income potential. As such, it could be a top performer.
Standard Life
After an up-and-down few years, where profit levels frequently jumped around, Standard Life (LSE: SL) is due to return to strong and steady double-digit growth over the next two years. Combined with a heady P/E ratio of 17.9, this still equates to a PEG ratio of 1, which highlights just how strong the insurance company’s forecasts are.
Such strong growth numbers should allow it to increase dividends at a rapid rate, although its current yield of 4.4% remains attractive and means that a mix of growth, value and income prospects could help shares in Standard Life to beat the FTSE 100.
RSA
Life as an RSA (LSE: RSA) shareholder has been tough in recent years, as allegations of wrongdoing have significantly hurt sentiment. However, new management seems to be turning the business around, with earnings due to rise by an impressive 14% next year. This puts RSA on an enticing PEG ratio of 0.9.
Although dividends are less than historic levels, RSA is still due to yield 3.6% next year. When combined with strong growth potential, this could be enough to push shares to higher highs.
Old Mutual
Trading on a P/E ratio of 10.5, shares in Old Mutual (LSE: OML) are dirt cheap. Indeed, concerns about the South African economy have held them back somewhat during 2014, being down 7% year-to-date.
However, the future could be much brighter for the insurer. That’s because its bottom line is all set to rise by 17% next year, which puts it on a hugely attractive PEG ratio of 0.5. Couple this with a growing yield of 5.1% and it’s difficult to justify anything but a share price rise over the medium term.
